Aigen Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,838
Closed -$236K 619
2021
Q1
$236K Buy
+4,838
New +$227K 0.03% 487
2020
Q3
Sell
-12,449
Closed -$329K 999
2020
Q2
$329K Buy
12,449
+12,327
+10,104% +$322K 0.04% 593
2020
Q1
$3K Sell
122
-814
-87% -$25.1K ﹤0.01% 1186
2019
Q4
$34K Buy
+936
New +$32.3K 0.01% 853

Other funds holding LMAT

Aigen Investment Management's LMAT Position: Q2 2021 in Review

Aigen Investment Management sold out of LeMaitre Vascular (LMAT) in Q2 2021, closing a stake of 4,838 shares — an estimated $236K sold.

Aigen Investment Management first reported a position in LMAT in Q4 2019 and held it in 4 quarters. The position peaked at $329K in Q2 2020. 185 funds tracked by Wall St. Rank hold LMAT as of Q2 2021.

  • Aigen Investment Management reported no remaining LeMaitre Vascular position as of Q2 2021 after selling out during the quarter.
  • Aigen Investment Management sold 4,838 LeMaitre Vascular shares in Q2 2021, an estimated $236K.
  • Aigen Investment Management first reported a position in LeMaitre Vascular in Q4 2019 and held it in 4 quarters.
  • Aigen Investment Management's LeMaitre Vascular position peaked at $329K in Q2 2020.
  • 185 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2021.

Based on Aigen Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.